University of Alberta

Running trials

• Not yet recruiting

  DESAL-HEART: Hypertonic Saline Added to a Pre-declared Furosemide Dose in Acute Heart Failure

  NCT07927127· Phase 4· University of Alberta· Source

• Not yet recruiting

  The Effect of Preoperative Pelvic Floor Physical Therapy (Prehabilitation) on Postoperative Pain Following Endometriosis Surgery: A Randomized Controlled Trial

  NCT07827794· University of Alberta· Source

• Not yet recruiting

  Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

  NCT07301424· Phase 2· University of Alberta· Source

• Not yet recruiting

  Ketone Ester for Treatment Of Acute Heart Failure

  NCT07434466· University of Alberta· Source

• Not yet recruiting

  Abdominal Neuromuscular Electrical Stimulation to Treat Neurogenic Bowel Dysfunction in Chronic SCI

  NCT07929558· Swiss Paraplegic Research, Nottwil· Source

• Not yet recruiting

  Applying Navigation and Care to Help Ongoing Retention

  NCT07834632· University of Alberta· Source

• Not yet recruiting

  INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  NCT07906275· Phase 3· University of Calgary· Source

• Recruiting

  AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  NCT07797335· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  NCT07687056· Phase 3· University of Calgary· Source

• Recruiting

  A Post Authorization Registry Study of Participants Treated With LEQEMBI

  NCT07762092· Eisai Limited· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Prilenia· Source

• Recruiting

  Timing of Rehabilitation Following Cervical Spinal Surgery in Degenerative Myelopathy

  NCT07636135· University of Alberta· Source

• Recruiting

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  NCT07470879· Phase 2· Pfizer· Source

• Recruiting

  Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

  NCT06705764· Phase 4· University of Alberta· Source

• Recruiting

  Improving Health Outcomes With Kefir

  NCT06695221· University of Alberta· Source

• Recruiting

  Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

  NCT07401680· Phase 1· University of Alberta· Source

• Recruiting

  Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

  NCT06555393· Phase 1· University of Alberta· Source

• Recruiting

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· Phase 3· Prilenia· Source

• Recruiting

  Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies

  NCT07339852· University of Alberta· Source

• Recruiting

  Effectiveness of NOA OATMAD

  NCT07111962· University of Alberta· Source

• Recruiting

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· Phase 3· argenx· Source

• Recruiting

  Feasibility Trial for a Right Ventricular Failure Platform Trial

  NCT06570473· Phase 2· University of Alberta· Source

• Recruiting

  COgnitioN With VERiciGuat Evaluation in Heart Failure

  NCT06601465· Phase 2· University of Alberta· Source

• Recruiting

  Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

  NCT06626022· Phase 3· University of Alberta· Source

• Recruiting

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease

  NCT06325280· University of Alberta· Source

• Recruiting

  Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

  NCT06748963· University of Alberta· Source

• Recruiting

  An Adaptive Design Study of MTX228

  NCT06474598· Phase 2· University of Alberta· Source

• Active, not recruiting

  A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

  NCT06564636· Smith & Nephew, Inc.· Source

• Recruiting

  ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

  NCT06320431· Phase 3· University of Calgary· Source

• Recruiting

  VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

  NCT06257706· Phase 4· Alimentiv Inc.· Source

• Recruiting

  Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study

  NCT06595147· University of Alberta· Source

• Active, not recruiting

  A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

  NCT06388200· Phase 3· Ocugen· Source

• Recruiting

  Transcutaneous Spinal Cord Stimulation for Upper Extremity Function

  NCT06596369· Phase 2/3· University of Alberta· Source

• Recruiting

  ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

  NCT06038032· University of Alberta· Source

• Active, not recruiting

  VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

  NCT06249555· Alimentiv Inc.· Source

• Recruiting

  Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer

  NCT06072911· University of Alberta· Source

• Recruiting

  Nerve Transfer to Improve Function in High Level Tetraplegia

  NCT06288763· Washington University School of Medicine· Source

• Active, not recruiting

  Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

  NCT06046222· Phase 2· NS Pharma, Inc.· Source

• Active, not recruiting

  Nutritional Management of Post COVID-19 Cognitive Symptoms

  NCT05705648· University of Alberta· Source

• Active, not recruiting

  Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources

  NCT05681468· University of Alberta· Source

• Recruiting

  Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

  NCT06051617· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Phase 3· Teva Branded Pharmaceutical Products R&D LLC· Source

• Recruiting

  Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

  NCT05955924· Phase 3· Women's College Hospital· Source

• Recruiting

  18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028

  NCT05520255· Phase 3· University of Alberta· Source

• Active, not recruiting

  A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

  NCT05791201· Phase 1/2· Vertex Pharmaceuticals Incorporated· Source

• Active, not recruiting

  A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

  NCT05633459· Phase 1· QurAlis Corporation· Source

• Recruiting

  HIIT in Youth With Congenital Heart Disease (MedBIKE)

  NCT04575883· University of Alberta· Source

• Active, not recruiting

  Attrition in Pediatric Obesity Management

  NCT05403658· University of Alberta· Source

• Active, not recruiting

  Symptomatic Carotid Outcomes Registry

  NCT05300737· University of Maryland, Baltimore· Source

Showing 50 of 95.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers6 recruiting
• Acute lymphoblastic leukaemia5 recruiting
• Heart failure5 recruiting
• Spinal cord injury5 recruiting
• Type 1 diabetes5 recruiting
• High blood pressure4 recruiting
• Stroke4 recruiting
• Obesity3 recruiting
• Prostate cancer3 recruiting
• Type 2 diabetes3 recruiting
• ALS (motor neurone disease)2 recruiting
• Asthma2 recruiting
• Colorectal cancer2 recruiting
• Congenital heart disease2 recruiting
• Head and neck cancer2 recruiting
• Liver cirrhosis2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Ulcerative colitis2 recruiting
• Acute myeloid leukaemia1 recruiting
• Alzheimer disease1 recruiting
• Brain aneurysm1 recruiting
• Chronic kidney disease1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Endometriosis1 recruiting
• Huntington's disease1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroendocrine tumours1 recruiting
• Obstructive sleep apnoea1 recruiting
• Osteoarthritis1 recruiting
• Parkinson disease1 recruiting
• Primary biliary cholangitis1 recruiting
• Sickle cell disease1 recruiting

Closed trials

• Terminated

  Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy

  NCT06543446· University of Rochester· Source

• Completed

  eMPower Mechanisms

  NCT06861465· University of Alberta· Source

• Completed

  Heavy Strength Training in Head and Neck Cancer Survivors

  NCT06289049· Phase 2· University of Alberta· Source

• Completed

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Hoffmann-La Roche· Source

• Completed

  Pediatric Early Rehabilitation in Acute Lymphoblastic Leukemia

  NCT06170385· University of Alberta· Source

• Withdrawn

  Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS

  NCT05830214· University of Alberta· Source

• Completed

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· Phase 3· Mineralys Therapeutics Inc.· Source

• Completed

  FFP Usage in Pediatric CV Surgery

  NCT05819788· University of Alberta· Source

• Completed

  A Web-based Platform to Improve Physical Function, Nutrition, and Mindfulness in Patients With Long COVID

  NCT05422924· University of Alberta· Source

• Completed

  Supporting Parents to Choose Wisely

  NCT06005337· University of Alberta· Source

• Terminated

  Diuretic Use in Hemodialysis Patients With Residual Renal Function

  NCT05915286· Phase 4· University of Alberta· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Mental Health Assessment and Prescribing by Alberta Pharmacists

  NCT04410575· University of Alberta· Source

• Completed

  Exercise and Cardiac Stunning During HD

  NCT04877041· University of Manitoba· Source

• Completed

  Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions

  NCT05786482· University of Alberta· Source

• Terminated

  An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D

  NCT05565248· Phase 1· CRISPR Therapeutics AG· Source

• Completed

  Digital Intervention for Behaviour Change and Chronic Disease Prevention

  NCT05579704· University of Alberta· Source

• Completed

  Digital Metabolic Rehabilitation COPD

  NCT05806294· University of Alberta· Source

• Completed

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· Phase 2· Escient Pharmaceuticals, Inc· Source

• Completed

  IBD Neoplasia Surveillance RCT

  NCT05809999· Ottawa Hospital Research Institute· Source

• Terminated

  Health Outcomes With CPAP or NIV in Patients With COPD and a Sleep Related Breathing Disorder

  NCT05623709· University of Alberta· Source

• Completed

  Home-based Early Intensive Hemiparesis Therapy: Engaging Nurture

  NCT05346887· University of Calgary· Source

• Completed

  A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

  NCT05054309· Société des Produits Nestlé (SPN)· Source

• Completed

  Virtual Remote Physiological Monitoring Program of Children With Heart Disease

  NCT05034354· University of Alberta· Source

• Completed

  The Impact of an Innovative eHealth Transition Intervention on Self-Management Skills Among Young Adults With Congenital Heart Disease

  NCT04463446· University of Alberta· Source

• Completed

  A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

  NCT04945460· Phase 2· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Source

• Completed

  Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI

  NCT05220501· Sunnybrook Health Sciences Centre· Source

• Completed

  DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

  NCT04963231· Phase 2· Rhythm Pharmaceuticals, Inc.· Source

• Completed

  Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis

  NCT04979546· University of Alberta· Source

• Terminated

  A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis

  NCT04948645· Phase 1· AbbVie· Source

• Withdrawn

  Role of Repeat Resection in Recurrent Glioblastoma

  NCT04838782· University of Alberta· Source

• Completed

  The Effect of Mandibular Advancement Devices on Markers of Cardiovascular Health in Obstructive Sleep Apnea Patients

  NCT05387122· University of Alberta· Source

• Completed

  Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease

  NCT06038344· University of Alberta· Source

• Completed

  Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

  NCT05716334· McGill University Health Centre/Research Institute of the McGill University Health Centre· Source

• Completed

  Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data

  NCT04966637· University of Alberta· Source

• Completed

  Combination Antiretroviral Therapy (cART) for PBC

  NCT03954327· Phase 2· University of Alberta· Source

• Terminated

  SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

  NCT04217304· Phase 2· University of Alberta· Source

• Withdrawn

  Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation

  NCT04711226· Phase 2· Anelixis Therapeutics, LLC· Source

• Completed

  Online Wellness Intervention for Primary Biliary Cholangitis (PBC)

  NCT04791527· University of Alberta· Source

• Completed

  Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

  NCT03969953· Phase 3· The George Institute· Source

• Completed

  A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

  NCT04266795· Phase 2· Takeda· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Pfizer· Source

• Completed

  Prebiotics and Diet to Reduce "Leaky" Gut in First Degree Relatives of Crohn's Disease Patients

  NCT03950336· University of Alberta· Source

• Completed

  Exercise Timing and Gestational Diabetes

  NCT05256615· University of Alberta· Source

• Completed

  A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease

  NCT03707730· Phase 2· Igy Inc.· Source

• Completed

  SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

  NCT03876457· University Hospitals Cleveland Medical Center· Source

• Completed

  The Alberta NutrIMM Study - Nutrition and Immunity

  NCT04291391· University of Alberta· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· Phase 3· Actelion· Source

• Completed

  Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer

  NCT03795493· University of Alberta· Source

• Completed

  Parent Therapist Partnership to Provide Early, Intensive Exercise in Perinatal Stroke

  NCT03672864· University of Alberta· Source

Showing 50 of 69.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke188 works · 14 trials
• Obesity150 works · 10 trials
• Heart failure148 works · 12 trials
• Chronic kidney disease75 works · 7 trials
• Crohn's disease70 works · 5 trials
• Type 2 diabetes69 works · 7 trials
• Prostate cancer56 works · 5 trials
• Asthma48 works · 5 trials
• COPD38 works · 4 trials
• Melanoma36 works · 1 trial
• Multiple sclerosis34 works · 5 trials
• Ulcerative colitis32 works · 2 trials
• Coronary artery disease30 works · 8 trials
• Ankylosing spondylitis29 works · 0 trials
• Spinal cord injury27 works · 7 trials
• Psoriasis26 works · 0 trials
• Congenital heart disease26 works · 5 trials
• Type 1 diabetes25 works · 11 trials
• ALS (motor neurone disease)24 works · 6 trials
• Systemic sclerosis (scleroderma)23 works · 0 trials
• Multiple myeloma23 works · 1 trial
• Autism20 works · 0 trials
• Atopic dermatitis (eczema)19 works · 0 trials
• Long COVID and ME/CFS18 works · 2 trials
• Lupus (SLE)17 works · 0 trials
• Childhood cancers17 works · 10 trials
• Insomnia17 works · 0 trials
• Pulmonary arterial hypertension16 works · 4 trials
• Dilated cardiomyopathy15 works · 0 trials
• Psoriatic arthritis15 works · 0 trials